These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20625645)

  • 21. Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
    Aubert RE; Herrera V; Chen W; Haffner SM; Pendergrass M
    Diabetes Obes Metab; 2010 Aug; 12(8):716-21. PubMed ID: 20590749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of thiazolidinediones on bone loss and fracture.
    Murphy CE; Rodgers PT
    Ann Pharmacother; 2007 Dec; 41(12):2014-8. PubMed ID: 17940125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone health in diabetes: considerations for clinical management.
    Adami S
    Curr Med Res Opin; 2009 May; 25(5):1057-72. PubMed ID: 19292601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Anti-diabetic agents and fracture risk].
    Okazaki R
    Clin Calcium; 2008 Aug; 18(8):1154-61. PubMed ID: 18677054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 diabetes and bone fractures.
    Moseley KF
    Curr Opin Endocrinol Diabetes Obes; 2012 Apr; 19(2):128-35. PubMed ID: 22262002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of diabetes drugs on the skeleton.
    Meier C; Schwartz AV; Egger A; Lecka-Czernik B
    Bone; 2016 Jan; 82():93-100. PubMed ID: 25913633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis.
    Billington EO; Grey A; Bolland MJ
    Diabetologia; 2015 Oct; 58(10):2238-46. PubMed ID: 26109213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of thiazolidinediones on BMD and osteoporosis.
    McDonough AK; Rosenthal RS; Cao X; Saag KG
    Nat Clin Pract Endocrinol Metab; 2008 Sep; 4(9):507-13. PubMed ID: 18695700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk.
    Barzilay JI; Davis BR; Pressel SL; Ghosh A; Puttnam R; Margolis KL; Whelton PK
    Curr Cardiol Rep; 2017 Sep; 19(9):76. PubMed ID: 28752275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study.
    Pallisgaard JL; Lindhardt TB; Staerk L; Olesen JB; Torp-Pedersen C; Hansen ML; Gislason GH
    Eur Heart J Cardiovasc Pharmacother; 2017 Jul; 3(3):140-146. PubMed ID: 28028073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiazolidinediones and bone.
    Falchetti A; Masi L; Brandia ML
    Clin Cases Miner Bone Metab; 2007 May; 4(2):103-7. PubMed ID: 22461209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type 2 diabetes, thiazolidinediones: bad to the bone?
    Watts NB; D'Alessio DA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3276-8. PubMed ID: 16960122
    [No Abstract]   [Full Text] [Related]  

  • 33. Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures.
    Kurra S; Siris E
    Diabetes Metab Res Rev; 2011 Jul; 27(5):430-5. PubMed ID: 21432981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of diabetes and diabetes medications on bone health.
    Gilbert MP; Pratley RE
    Endocr Rev; 2015 Apr; 36(2):194-213. PubMed ID: 25738213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes medications and bone.
    Grey A
    Curr Osteoporos Rep; 2015 Feb; 13(1):35-40. PubMed ID: 25433437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study.
    Hsiao FY; Mullins CD
    Diabetologia; 2010 Mar; 53(3):489-96. PubMed ID: 19943156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes and skeletal health.
    Yaturu S
    J Diabetes; 2009 Dec; 1(4):246-54. PubMed ID: 20923525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial.
    Grey A; Bolland M; Fenwick S; Horne A; Gamble G; Drury PL; Reid IR
    Eur J Endocrinol; 2014 Feb; 170(2):255-62. PubMed ID: 24217934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing and maintaining bone mineral density in diabetes patients with pharmacotherapy.
    Fixen CW; Fixen DR
    Expert Opin Pharmacother; 2017 Dec; 18(18):2001-2006. PubMed ID: 29172834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.